Target Validation Information
Target ID T55916
Target Name Potassium voltage-gated channel subfamily KQT member 4
Target Type
Research
Drug Potency against Target Retigabine Drug Info EC50 = 1600 nM [525854]
References
Ref 525854Mol Pharmacol. 2000 Sep;58(3):591-600.Retigabine, a novel anti-convulsant, enhances activation of KCNQ2/Q3 potassium channels.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.